Suhas Shivaji Siddheshwar, Mr. Ankur Machhindra Jadhav, Someshwar Dattatraya Mankar, Arti Changdev Ghorpade, Pratibha Bhalerao
{"title":"阿那非共晶的开发和优化:提高水溶性和溶解速率的硅分子对接方法","authors":"Suhas Shivaji Siddheshwar, Mr. Ankur Machhindra Jadhav, Someshwar Dattatraya Mankar, Arti Changdev Ghorpade, Pratibha Bhalerao","doi":"10.1016/j.molstruc.2025.144281","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Avanafil, a second-generation phosphodiesterase type-5 inhibitor, demonstrates poor aqueous solubility (0.058 mg/mL) resulting in variable bioavailability and suboptimal therapeutic outcomes in erectile dysfunction treatment. The limited dissolution rate significantly impacts drug absorption and clinical efficacy.</div></div><div><h3>Objective</h3><div>To develop and optimize avanafil-nicotinamide cocrystals using systematic molecular docking approach for enhanced aqueous solubility and dissolution performance, addressing critical biopharmaceutical limitations.</div></div><div><h3>Methods</h3><div>Computational screening evaluated potential coformers through binding energy analysis using validated molecular docking protocols. Cocrystals were prepared via solvent evaporation method and optimized using three-factor factorial design. Comprehensive characterization employed differential scanning calorimetry, Fourier-transform infrared spectroscopy, powder X-ray diffraction, and dissolution studies. Optimized formulations were developed into immediate-release tablets and evaluated for pharmacokinetic performance in animal studies.</div></div><div><h3>Results</h3><div>Molecular docking successfully identified nicotinamide as optimal coformer with strongest binding energy and extensive interaction network. The optimized cocrystal demonstrated significant solubility enhancement with superior dissolution profiles compared to pure drug and marketed formulations. Tablet formulation exhibited accelerated drug absorption, enhanced bioavailability, and improved pharmacokinetic parameters including reduced time to maximum concentration and increased area under curve.</div></div><div><h3>Conclusion</h3><div>Systematic cocrystal engineering approach successfully enhanced avanafil's biopharmaceutical properties through rational molecular design, providing validated methodology for pharmaceutical development.</div></div><div><h3>Future Scope</h3><div>Human bioequivalence trials, GMP manufacturing validation, Zone IV stability studies, and patient acceptability assessments are essential for clinical translation.</div></div>","PeriodicalId":16414,"journal":{"name":"Journal of Molecular Structure","volume":"1351 ","pages":"Article 144281"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and optimization of avanafil cocrystals: in silico molecular docking approach for enhanced aqueous solubility and dissolution rate\",\"authors\":\"Suhas Shivaji Siddheshwar, Mr. Ankur Machhindra Jadhav, Someshwar Dattatraya Mankar, Arti Changdev Ghorpade, Pratibha Bhalerao\",\"doi\":\"10.1016/j.molstruc.2025.144281\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Avanafil, a second-generation phosphodiesterase type-5 inhibitor, demonstrates poor aqueous solubility (0.058 mg/mL) resulting in variable bioavailability and suboptimal therapeutic outcomes in erectile dysfunction treatment. The limited dissolution rate significantly impacts drug absorption and clinical efficacy.</div></div><div><h3>Objective</h3><div>To develop and optimize avanafil-nicotinamide cocrystals using systematic molecular docking approach for enhanced aqueous solubility and dissolution performance, addressing critical biopharmaceutical limitations.</div></div><div><h3>Methods</h3><div>Computational screening evaluated potential coformers through binding energy analysis using validated molecular docking protocols. Cocrystals were prepared via solvent evaporation method and optimized using three-factor factorial design. Comprehensive characterization employed differential scanning calorimetry, Fourier-transform infrared spectroscopy, powder X-ray diffraction, and dissolution studies. Optimized formulations were developed into immediate-release tablets and evaluated for pharmacokinetic performance in animal studies.</div></div><div><h3>Results</h3><div>Molecular docking successfully identified nicotinamide as optimal coformer with strongest binding energy and extensive interaction network. The optimized cocrystal demonstrated significant solubility enhancement with superior dissolution profiles compared to pure drug and marketed formulations. Tablet formulation exhibited accelerated drug absorption, enhanced bioavailability, and improved pharmacokinetic parameters including reduced time to maximum concentration and increased area under curve.</div></div><div><h3>Conclusion</h3><div>Systematic cocrystal engineering approach successfully enhanced avanafil's biopharmaceutical properties through rational molecular design, providing validated methodology for pharmaceutical development.</div></div><div><h3>Future Scope</h3><div>Human bioequivalence trials, GMP manufacturing validation, Zone IV stability studies, and patient acceptability assessments are essential for clinical translation.</div></div>\",\"PeriodicalId\":16414,\"journal\":{\"name\":\"Journal of Molecular Structure\",\"volume\":\"1351 \",\"pages\":\"Article 144281\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Molecular Structure\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022286025029254\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, PHYSICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Structure","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022286025029254","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
Development and optimization of avanafil cocrystals: in silico molecular docking approach for enhanced aqueous solubility and dissolution rate
Background
Avanafil, a second-generation phosphodiesterase type-5 inhibitor, demonstrates poor aqueous solubility (0.058 mg/mL) resulting in variable bioavailability and suboptimal therapeutic outcomes in erectile dysfunction treatment. The limited dissolution rate significantly impacts drug absorption and clinical efficacy.
Objective
To develop and optimize avanafil-nicotinamide cocrystals using systematic molecular docking approach for enhanced aqueous solubility and dissolution performance, addressing critical biopharmaceutical limitations.
Methods
Computational screening evaluated potential coformers through binding energy analysis using validated molecular docking protocols. Cocrystals were prepared via solvent evaporation method and optimized using three-factor factorial design. Comprehensive characterization employed differential scanning calorimetry, Fourier-transform infrared spectroscopy, powder X-ray diffraction, and dissolution studies. Optimized formulations were developed into immediate-release tablets and evaluated for pharmacokinetic performance in animal studies.
Results
Molecular docking successfully identified nicotinamide as optimal coformer with strongest binding energy and extensive interaction network. The optimized cocrystal demonstrated significant solubility enhancement with superior dissolution profiles compared to pure drug and marketed formulations. Tablet formulation exhibited accelerated drug absorption, enhanced bioavailability, and improved pharmacokinetic parameters including reduced time to maximum concentration and increased area under curve.
Conclusion
Systematic cocrystal engineering approach successfully enhanced avanafil's biopharmaceutical properties through rational molecular design, providing validated methodology for pharmaceutical development.
Future Scope
Human bioequivalence trials, GMP manufacturing validation, Zone IV stability studies, and patient acceptability assessments are essential for clinical translation.
期刊介绍:
The Journal of Molecular Structure is dedicated to the publication of full-length articles and review papers, providing important new structural information on all types of chemical species including:
• Stable and unstable molecules in all types of environments (vapour, molecular beam, liquid, solution, liquid crystal, solid state, matrix-isolated, surface-absorbed etc.)
• Chemical intermediates
• Molecules in excited states
• Biological molecules
• Polymers.
The methods used may include any combination of spectroscopic and non-spectroscopic techniques, for example:
• Infrared spectroscopy (mid, far, near)
• Raman spectroscopy and non-linear Raman methods (CARS, etc.)
• Electronic absorption spectroscopy
• Optical rotatory dispersion and circular dichroism
• Fluorescence and phosphorescence techniques
• Electron spectroscopies (PES, XPS), EXAFS, etc.
• Microwave spectroscopy
• Electron diffraction
• NMR and ESR spectroscopies
• Mössbauer spectroscopy
• X-ray crystallography
• Charge Density Analyses
• Computational Studies (supplementing experimental methods)
We encourage publications combining theoretical and experimental approaches. The structural insights gained by the studies should be correlated with the properties, activity and/ or reactivity of the molecule under investigation and the relevance of this molecule and its implications should be discussed.